Modification of collagen matrices for enhancing angiogenesis

Cells Tissues Organs

Volumn 178, Issue 4, 2004, Pages 189-196

  Yao, Chang ^a   Prével, Pascale ^a   Koch, Sabine ^a   Schenck, Peter ^b   Noah, Ernst Magnus ^a   Pallua, Norbert ^a   Steffens, Guy ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b Dr Suwelack Skin and Health Care AG   (Germany)

Author keywords

Angiogenesis; Animal model; Collagen matrices; Heparin; Vascular endothelial growth factor

Indexed keywords

COLLAGEN; COLLAGENASE; HEMOGLOBIN; HEPARIN; ANGIOGENIC FACTOR; CROSS LINKING REAGENT; OXYGEN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; COMPARATIVE STUDY; CONTROLLED STUDY; COVALENT BOND; ENZYME DEGRADATION; EXPLANT; HEMOGLOBIN DETERMINATION; IN VITRO STUDY; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; TISSUE ENGINEERING; ANIMAL; CHEMISTRY; CULTURE TECHNIQUE; IMMUNOHISTOCHEMISTRY; LEWIS RAT; METABOLISM; METHODOLOGY; NEOVASCULARIZATION (PATHOLOGY);

ANIMALIA;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; COLLAGEN; CROSS-LINKING REAGENTS; CULTURE TECHNIQUES; HEMOGLOBINS; HEPARIN; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; RATS; RATS, INBRED LEW; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 20544433465     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083730     Document Type: Article

References (18)

1. 2 by binding to injectable fibrillar collagen via difunctional polyethylene glycol. J Biomed Mater Res 39:539-548.
2. Davis, G.E., K.J. Bayless, A. Mavila (2002) Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices. Anat Rec 265:252-275.
3. Hinrichs, W.L.J., H.W.M. ten Hoopen, M.J.B. Wissink, G.H.M. Engbers, J. Feijen (1997) Design of a new type of coating for the controlled release of heparin. J Control Release 45:163-176.
4. Kusaka, M., K. Sudo, T. Fujita, S. Marui, F. Itoh, D. Ingber, J. Folkman (1991) Potent anti-angiogenic action of AGM-1470: Comparison to the fumagillin parent. Biochem Biophys Res Commun 174:1070-1076.
5. Olde Damink, L.H., P.J. Dijkstra, M.J. van Luyn, P.B. van Wachem, P. Nieuwenhuis, J. Feijen (1996) Cross-linking of dermal sheep collagen using a water-soluble carbodiimide. Biomaterials 17:765-773.
6. Pieper, J.S., T. Hafmans, P.B. Van Wachem, M.J. Van Luyn, L.A. Brouwer, J.H. Veerkamp, T.H. Van Kuppevelt (2002) Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J Biomed Mater Res 62:185-194.
7. Ribatti, D., A. Vacca, M. Presta (2000) The discovery of angiogenic factors: A historical review. Gen Pharmacol 55:227-231.
8. Senger, D.R., L. Van de Water, L.F. Brown, J.A. Nagy, K.T. Yeo, T.K. Yeo, B. Berse, R.W. Jackman, A.M. Dvorak, H.F. Dvorak (1993) Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 72:303-324.
9. Smith, P.K., A.K. Mallia, G.T. Hermanson (1980) Colorimetric method for the assay of heparin content in immobilized heparin preparations. Anal Biochem 709:466-473.
10. Soker, S., M. Machado, A. Atala (2000) Systems for therapeutic angiogenesis in tissue engineering. World J Urol 75:10-18.
11. Steffens, G.C.M., P. Prevel, S. Koch, C. Yao, M. Markowicz, E.M. Noah, N. Pallua (2002) Enhancing angiogenic capabilities of collagen matrices by immobilizing growth factors. 5th Annual Meeting of the Tissue Engineering Society International, Kobe, Japan. Tissue Eng 8:1153.
12. Tabata, Y., Y. Ikada (1999) Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials 20:2169-2175.
13. Tessler, S., P. Rockwell, D. Hicklin, T. Cohen, B.Z. Levi, L. Witte, I.R. Lemischka, G. Neufeld (1994) Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. J Biol Chem 269:12456-12461.
14. Wissink, M.J., R. Beernink, J.S. Pieper, A.A. Pool, G.H. Engbers, T. Beugeling, W.G. van Aken, J. Feijen (2001a) Binding and release of basic fibroblast growth factor from heparinized collagen matrices. Biomaterials 22:2291-2299.
15. Wissink, M.J., R. Beernink, J.S. Pieper, A.A. Poot, G.H. Engbers, T. Beugeling, W.G. van Aken, J. Feijen (2001b) Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation. Biomaterials 22:151-163.
16. Wissink, M.J., R. Beernink, N.M. Scharenborg, A.A. Poot, G.H. Engbers, T. Beugeling, W.G. van Aken, J. Feijen (2000a) Endothelial cell seeding of (heparinized) collagen matrices: Effects of bFGF pre-loading on proliferation (after low density seeding) and pro-coagulant factors. J Control Release 67:141-155.
17. Wissink, M.J., M.J. van Luyn, R. Beernink, F. Dijk, A.A. Poot, G.H. Engbers, T. Beugeling, W.G. van Aken, J. Feijen (2000b) Endothelial cell seeding on crosslinked collagen: Effects of crosslinking on endothelial cell proliferation and functional parameters. Thromb Haemost 54:325-331.
18. Zeeman, R. (1998) Cross-linking of collagen-based materials; PhD thesis, University of Twente, The Netherlands.